Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Cullinan Oncology, Inc. | 10%+ Owner | Common Stock | 1.31M | $16.3M | $12.46 | Jun 24, 2022 | By F2 Vision SCS |
Cullinan Oncology, Inc. | 10%+ Owner | Common Stock | 1.14M | $14.2M | $12.46 | Jun 24, 2022 | By Globeways Holdings Ltd. |
Allovir, Inc. | Director, 10%+ Owner | Common Stock | 16.7M | $13.2M | $0.79 | Jun 6, 2024 | Shares held by ElevateBio LLC |
Cullinan Oncology, Inc. | 10%+ Owner | Common Stock | 622K | $7.75M | $12.46 | Jun 24, 2022 | By F2-TPO Investments, LLC |
Cullinan Oncology, Inc. | 10%+ Owner | Common Stock | 537K | $6.7M | $12.46 | Jun 24, 2022 | By F2 Bioscience I 2017 Ltd. |
Cullinan Oncology, Inc. | 10%+ Owner | Common Stock | 325K | $4.05M | $12.46 | Jun 24, 2022 | By F2 MG Ltd. |
Allovir, Inc. | Director, 10%+ Owner | Common Stock | 4.19M | $3.32M | $0.79 | Jun 6, 2024 | F2 Capital I 2020 LLC |
Cullinan Oncology, Inc. | 10%+ Owner | Common Stock | 215K | $2.68M | $12.46 | Jun 24, 2022 | By F2 MC, LLC |
Cullinan Oncology, Inc. | 10%+ Owner | Common Stock | 208K | $2.59M | $12.46 | Jun 24, 2022 | Direct |
Allovir, Inc. | Director, 10%+ Owner | Common Stock | 2.06M | $1.63M | $0.79 | Jun 6, 2024 | F2 MG Ltd. |
Allovir, Inc. | Director, 10%+ Owner | Common Stock | 2.04M | $1.62M | $0.79 | Jun 6, 2024 | Shares held by F2 MC, LLC |
Cullinan Oncology, Inc. | 10%+ Owner | Common Stock | 105K | $1.31M | $12.46 | Jun 24, 2022 | By F2 GC, LLC |
Cullinan Oncology, Inc. | 10%+ Owner | Common Stock | 71.6K | $892K | $12.46 | Jun 24, 2022 | By F2 Bio TD, LLC |
Allovir, Inc. | Director, 10%+ Owner | Common Stock | 868K | $687K | $0.79 | Jun 6, 2024 | F2 Bioscience AV 2022 LLC |
Allovir, Inc. | Director, 10%+ Owner | Common Stock | 668K | $529K | $0.79 | Jun 6, 2024 | Shares held by F2 TPO Investments, LLC |
Allovir, Inc. | Director, 10%+ Owner | Common Stock | 100K | $79.4K | $0.79 | Jun 6, 2024 | Direct |
Cullinan Oncology, Inc. | 10%+ Owner | Stock Option (Right to Buy) | 0 | Jun 24, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ALVR | Allovir, Inc. | Jun 6, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director, 10%+ Owner |
ALVR | Allovir, Inc. | May 11, 2023 | 1 | $0 | 4 | May 12, 2023 | Director, 10%+ Owner |
ALVR | Allovir, Inc. | Jul 28, 2022 | 6 | $37.6M | 4 | Aug 1, 2022 | Director, 10%+ Owner |
CGEM | Cullinan Oncology, Inc. | Jun 24, 2022 | 5 | $13.80 | 4 | Jun 28, 2022 | 10%+ Owner |
ALVR | Allovir, Inc. | May 17, 2022 | 1 | $0 | 4 | May 19, 2022 | Director, 10%+ Owner |
ALVR | Allovir, Inc. | Nov 10, 2021 | 2 | -$19.8K | 4 | Nov 15, 2021 | Director |
ALVR | Allovir, Inc. | Nov 5, 2021 | 4 | -$302K | 4 | Nov 9, 2021 | Director |
ALVR | Allovir, Inc. | Oct 27, 2021 | 2 | -$54.5K | 4 | Oct 29, 2021 | Director |
ALVR | Allovir, Inc. | Oct 21, 2021 | 6 | -$337K | 4 | Oct 25, 2021 | Director |
CGEM | Cullinan Oncology, Inc. | Sep 16, 2021 | 1 | $0 | 4 | Mar 25, 2022 | Director |
ALVR | Allovir, Inc. | May 25, 2021 | 1 | $0 | 4 | May 27, 2021 | Director, 10%+ Owner |